603882.SS SHH
Guangzhou Kingmed Diagnostics Group Co., Ltd.
1W: +0.0%
1M: +6.1%
3M: +24.1%
YTD: -9.5%
1Y: -3.8%
3Y: -58.6%
5Y: -77.8%
¥29.06 ($4.34)
+0.81 (+2.87%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$10.4B
-11.7% ▼
5Y CAGR: +18.8%
Total Liabilities
$2.9B
-9.4% ▼
5Y CAGR: +7.1%
Shareholders Equity
$7.3B
-12.4% ▼
5Y CAGR: +26.4%
Cash & Investments
$2.4B
-1.0% ▼
5Y CAGR: +20.6%
Total Debt
$634M
+41.3% ▲
5Y CAGR: +0.6%
Net Debt
-$1.8B
+4.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.6B | $2.7B | $2.9B | $2.5B | $2.4B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $1.6B | $2.7B | $2.9B | $2.5B | $2.4B |
| Net Receivables | $2.8B | $4.8B | $7.2B | $5.5B | $4.5B |
| Inventory | $238M | $345M | $405M | $248M | $198M |
| Other Current Assets | $117M | $128M | $190M | $74M | $166M |
| Total Current Assets | $4.8B | $7.9B | $10.7B | $8.3B | $7.3B |
| Property, Plant & Equip. | $1.2B | $2.0B | $2.2B | $2.3B | $2.0B |
| Goodwill & Intangibles | $152M | $82M | $185M | $203M | $223M |
| Long-Term Investments | $444M | $587M | $378M | $584M | $0 |
| Other Non-Current Assets | $41M | $148M | $369M | $245M | $641M |
| Total Non-Current Assets | $1.9B | $2.8B | $3.2B | $3.5B | $3.1B |
| Total Assets | $6.6B | $10.8B | $13.9B | $11.8B | $10.4B |
| — Liabilities — | |||||
| Accounts Payable | $1.6B | $2.3B | $3.0B | $2.1B | $1.7B |
| Short-Term Debt | $37M | $0 | $0 | $1M | $1M |
| Deferred Revenue | $602M | $1.2B | $105M | $0 | $0 |
| Other Current Liabilities | $138M | $333M | $327M | $608M | $456M |
| Total Current Liabilities | $2.3B | $3.7B | $4.6B | $2.7B | $2.2B |
| Long-Term Debt | $379M | $249M | $143M | $268M | $515M |
| Other Non-Current Liab. | -$79M | $37M | $0 | $25M | $0 |
| Total Non-Current Liabilities | $451M | $500M | $435M | $531M | $684M |
| Total Liabilities | $2.8B | $4.2B | $5.0B | $3.2B | $2.9B |
| — Equity — | |||||
| Common Stock | $459M | $466M | $467M | $469M | $463M |
| Retained Earnings | $2.3B | $4.2B | $6.4B | $6.2B | $5.4B |
| Accumulated OCI | $158M | $313M | $436M | $0 | $0 |
| Total Stockholders Equity | $3.8B | $6.3B | $8.6B | $8.4B | $7.3B |
| Total Liabilities & Equity | $6.6B | $10.8B | $13.9B | $11.8B | $10.4B |
| — Key Metrics — | |||||
| Total Debt | $462M | $622M | $568M | $449M | $634M |
| Net Debt | -$1.2B | -$2.0B | -$2.4B | -$1.9B | -$1.8B |
| Total Investments | $444M | $587M | $378M | $584M | $0 |